Aptevo Therapeutics Inc.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-3.04 | $-3.15 |
| FY2022 | $0.79 | $-2.65 |
| FY2023 | $-2,316.83 | $-267.38 |
| FY2024 | $-31,460.23 | $-3,386.67 |
| FY2025 | $-87.27 | $-3,395.20 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2021 | $-3.04 | $-3.15 |
| FY2022 | $0.79 | $-2.65 |
| FY2023 | $-2,316.83 | $-267.38 |
| FY2024 | $-31,460.23 | $-3,386.67 |
| FY2025 | $-87.27 | $-3,395.20 |